Sandra Robelet

Chronic <scp>l</scp>‐DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease

Sandra Robelet, Christophe Melon, Benjamin Guillet et al. · European Journal of Neuroscience · 2004 · 157 citations

Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson’s disease

Rodolphe Hajj, Aude Milet, Damien Toulorge et al. · Scientific Reports · 2015 · 57 citations · Full text

&lt;p&gt;Effect of the micro-immunotherapy medicine 2LPARK® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson’s disease&lt;/p&gt;

Nicoletta Libera Lilli, Delphine Révy, Sandra Robelet et al. · Degenerative Neurological and Neuromuscular Disease · 2019 · 10 citations · Full text